Seeking Alpha
14 Oct 2026, 07:23 UTC · 1h ago
Inventiva: Significant Upside Potential Ahead Of Pivotal Liver Disease Readout
Impact · against what's priced in
Inventiva is positioned for a binary event with the imminent NATiV3 readout. While the potential upside is significant, the current price reflects a speculative state where the outcome is unknown, making the analyst's valuation a target rather than a catalyst.
- IVA+0.10
No priced-in read yet
- In context
The imminent Phase 3 NATiV3 readout is the primary driver; while the analyst sees a 40% probability of a $29 fair value, the market is currently pricing in a high-risk binary outcome at $3.20.
Read from the article alone
Top 1 mover · tap to explore
